Results 241 to 250 of about 4,391,095 (303)

Multiple Sclerosis Relapse Activity After Ozanimod Discontinuation in DAYBREAK Trial Participants

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
Multiple Sclerosis Relapse Activity After Ozanimod Discontinuation in DAYBREAK Trial Participants. ABSTRACT Objective Return of disease activity is expected when patients discontinue disease‐modifying therapy (DMT) for multiple sclerosis (MS). Some MS DMTs are associated with higher‐than‐expected disease activity (rebound) after discontinuation.
Ralf Gold   +12 more
wiley   +1 more source

Experience-based risk taking is primarily shaped by prior learning rather than by decision-making. [PDF]

open access: yesNat Commun
Erdman A   +6 more
europepmc   +1 more source

CSF Monoamine Metabolites and Cognitive Trajectory in Early Parkinson's Disease

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Imaging and postmortem studies indicate that abnormalities in monoaminergic neurotransmission contribute to cognitive impairment in Parkinson's disease (PD). However, it remains uncertain if cerebrospinal fluid (CSF) monoamine metabolites can serve as biomarkers of cognitive decline in early PD.
Jing‐Yu Shao   +7 more
wiley   +1 more source

Effects of aging and risk-taking behaviors on fatal injuries among old motorcyclists in Taiwan: Evidence from 2011 to 2022. [PDF]

open access: yesPLoS One
Widodo AF   +13 more
europepmc   +1 more source

The effects of power posing on neuroendocrine levels and risk-taking. [PDF]

open access: yesBMC Psychol
Barel E   +5 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy